Monday, 17 August 2026European Markets
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agent Rollout Outpaces Data Trust and Readiness
Enterprise adoption of agentic AI is accelerating fast — Siemens deepening its NVIDIA partnership for self-verifying agentic AI in chip design, Manulife expanding its Microsoft AI-governance partnership, and a wave of infrastructure launches (NVIDIA GPU-accelerated data processing, Dell exascale storage, new AI chip generations) — even as a new Google Cloud survey shows the underlying data foundation isn't ready: companies have AI access to only 45% of their data on average, data laggards see access fall to 30% or less, and only about half of organizations trust their AI agents' decisions. Meanwhile, insider selling at enterprise-AI bellwether C3.ai (CEO Thomas Siebel offloading $4.8M in shares) hints at investor caution layered under the adoption hype.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts report JPMorgan Chase & Co.'s revenue for the same fiscal period (FY 2025) with the same observation date (2025-12-31), but with different values: $182.447 billion vs. $185 billion. The ~1.4% difference ($2.553 billion) is too large to be explained by rounding alone and represents conflicting data for the identical time period.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,810
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,810 facts checked against source5,217 source documents archived
Work with this data → vianewsagency.com

MAUNA KEA TECH Stock Impressive Jump 19% So Far On Friday, Outperforms Market

Loading stream...

(vianews) - shares of mauna kea tech (cac 40: mkea.pa) jumped by a staggering 19.77% to €0.72 at 11:57 est on friday, after two sequential sessions in a row of losses. cac 40 is rising 0.17% to €7,551.29, following the last session's downward trend. this seems, up to now, a somewhat up trend trading session today.

mauna kea tech's last close was €0.60, 39.9% below its 52-week high of €0.99.

about mauna kea tech

mauna kea technologies sa develops and markets medical devices in europe and internationally. the company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. its flagship product is cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. the company was incorporated in 2000 and is headquartered in paris, france.

earnings per share

as for profitability, mauna kea tech has a trailing twelve months eps of €-0.27.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, mauna kea tech's stock is considered to be overbought (>=80).

volume

today's last reported volume for mauna kea tech is 1488239 which is 337.99% above its average volume of 339784.

more news about mauna kea tech (mkea.pa).